Forward agenda is conversion work: management's own stated priorities are about turning already-secured growth into resu
The model's full reasoning — Q3 2018 call → NOWe need to determine if the forward agenda is substantially about converting already secured growth into delivered results, and if management conveys that reported results do not yet meaningfully reflect that secured growth. Key points from the transcript: - Management discusses new product launches (Aimovig, Repatha, Prolia, biosimilars) with strong growth. They mention "new and recently launched products had double-digit unit volume growth." They talk about "launch progress" and "pipeline advancement." - For Aimovig: "over 100,000 patients starting Aimovig since launch." They mention "we expect prescription activity to moderate and normalize over the coming weeks." They talk about "first mover advantage" and "differentiated product profile." They are investing in patient education and DTC advertising. This seems like they are still in the pursuit of market share and winning demand, not just converting secured orders. - For Repatha: They made a decision to lower list price to improve access for Medicare Part D patients. They say "this should substantially lower their out-of-pocket costs and lower the abandonment rate." They expect "positive impact on volume growth." This is about improving access and winning more patients, not converting already secured business. - For biosimilars: They launched KANJINTI and AMGEVITA in Europe. They say "we are excited to have launched" and "we expect this business to be an important growth driver." They have "eight additional biosimilar programs in development." This is early stage, not yet secured growth. - For pipeline: They have seven new early stage clinical programs. They are "advancing through the oncology pipeline." This is about future potential, not secured. - The forward agenda seems to be about launching new products, expanding access, winning market share, and advancing pipeline. They are not talking about converting already secured orders or contracts. They are talking about pursuing growth. - The reported results: They had revenue growth of 2% and product sales growth of 1%. They mention "strong unit volume growth in our new and recently launched products outpaced declines in our mature brands." But they don't say that the secured growth is still ahead of the numbers. They are reporting current performance.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| HY | Hyster-Yale Materials Handling, Inc. | Q3 2021 | 2021-11-06 | D |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
EVGO · Q2 2022 → YESThe question is about whether management's forward agenda is about converting already secured growth into results, and if the reported results don't yet reflect that growth. YES The forward agenda centers on converting already-secured growth: the Pilot-GM eXtend deal (up to 2,000 stalls + 500 locations) is described as recently announced and exceeding IRR hurdles, with EVgo procuring, constructing, operating, and maintaining the assets on a capital-light basis; the 2022 guidance is affirmed and tracked, with heavier second-half loads explicitly tied to PFJ and fleet contractual revenues kicking in Q3/Q4 (some already baked into forecasts after late-2021 negotiations); current stall counts (2,397 in operation/under construction, 3,669 pipeline) and throughput explicitly exclude the 2,000-stall Pilot contribution; Delta supply agreement covers the first phase of the PFJ deal through 2026; and execution themes include ramping stalls, commissioning, fleet onboarding, and regulatory credit recognition tied to these committed contracts. The reported Q2 results ($9.1M revenue, 10.
BRBR · Q4 2023 → YESThe question is: On this call, when management describes what the company is focused on over the coming quarters — its own stated priorities, tasks, and to-do list — is that forward agenda substantial...YES The forward agenda centers on converting already-secured growth by ramping production (17% growth in fiscal '23, 20%+ planned for '24 via new co-mans and Michael Foods startup in December), restarting promotions and marketing once supply allows, and scaling the transformed co-man network to fulfill committed demand — all while noting tight supply dynamics persisting through most of fiscal '24. Management explicitly conveys that the reported FY '23 results (22% sales growth, 25% EBITDA growth) reflect only a portion of the secured trajectory, with the bulk of new capacity contributions and promotional lift still ahead in fiscal '24, treating 10-15% sales and 6-15% EBITDA guidance as the meaningful next step rather than a routine continuation.
EFXT · Q3 2023 → YESThe question is: Does management describe their focus over coming quarters as converting already secured growth into delivered results, AND do they convey that reported results don't yet meaningfully ...YES The transcript shows management's forward agenda centers on converting secured growth: executing on the $1.6 billion Engineered Systems backlog for 2024 revenue visibility, realizing remaining USD 60 million synergies from Exterran integration, consolidating facilities, and prioritizing debt reduction plus operational efficiency. They describe this as turning already-committed 2024 activity into delivered results, with the backlog providing "strong visibility into revenue generation and business activity levels for 2024" and embedded margins in line with mid-teens targets.